CHG-2021-0164

Facility Change for Glucovantib. Formulation Change for Glucovantib — routine update. Impacts 8 markets and 5 variations.

Change Number
CHG-2021-0164
Type
Facility Change
Product
Glucovantib
Status
Overdue
Owner
Sarah Chen
Initiated
2022-08-22
Description

Formulation Change for Glucovantib — routine update

Impacted Markets (8)
BR — BrazilAU — AustraliaES — SpainSG — SingaporeAR — ArgentinaZA — South AfricaPL — PolandSE — Sweden
Impacted Modules
2.3.P3.2.P.33.2.S
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved